Post Marketing Surveillance on Long Drug Use of Micombi Combination Tablets in Patients With Hypertension
Post Marketing Surveillance on Long Drug Use of Micombi Combination Tablets in Patients With Hypertension
The survey is conducted to collect safety and effectiveness information in Hypertensive patients treated with Micombi Tablets on the long term use in daily clinical settings in Japan.
Inclusion criteria:
Hypertensive patients who have never taken Micombi Tablets.
Exclusion criteria:
None
Aisho-cho, Japan
Aizubange-machi, Japan
Chikujo-machi, Japan
Gonohe-machi, Japan
Iwafune-machi, Japan
Kawatana-cho, Japan
Kusu-machi, Japan
Matsuda-machi, Japan
Mukawa-cho, Japan
Ninomiya-machi, Japan
Odai-cho, Japan
Shime-machi, Japan
Tokyo Adachi-ku, Japan
Tokyo Adachi-ku, Japan
Tokyo Bunkyo-ku, Japan
Tokyo Chiyoda-ku, Japan
Tokyo Chiyoda-ku, Japan
Tokyo Kita-ku, Japan
Tokyo Koto-ku, Japan
Tokyo Meguro-ku, Japan
Tokyo Meguro-ku, Japan
Tokyo Nerima-ku, Japan
Tokyo Ota-ku, Japan
Tokyo Ota-ku, Japan
Tokyo Setagaya-ku, Japan
Tokyo Setagaya-ku, Japan
Tokyo Shibuya-ku, Japan
Tokyo Shinagawa-ku, Japan
Tokyo Shinagawa-ku, Japan
Tokyo Shinagawa-ku, Japan
Tokyo Shinjuku-ku, Japan
Tokyo Suginami-ku, Japan
Tokyo Sumida-ku, Japan
Tokyo Toshima-ku, Japan
Toyako-machi, Japan
Tsurugi-cho, Japan
Yamatokooriyama, Japan
Yosano-cho, Japan
Yoshika-cho, Japan